The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Pharmaceuticals leader AstraZeneca is to ramp up its in-house transactional capability in preparation for a sharp increase in M&A work.
AstraZeneca company secretary and solicitor Graeme Musker plans to bulk up his 25-strong UK legal team to cope with the demand for acquisition and licensing advice.
The company wants to boost its drug pipeline by buying up smaller life sciences operations following the launch of its externalisation strategy. Musker said: “I think we’re ready to increase numbers to deal with externalisation, especially in the licensing and acquisition area. We have to control costs and budgets, but the management is aware we have to step up to this challenge.”
Musker said he had no set limit in mind for the number of new recruits. “We have to judge it against the workflow coming in, which is very difficult to judge accurately. What we don’t want is to get people in and then see the workflow dry up,” he said.